Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer
暂无分享,去创建一个
Nihal Ahmad | R. Reiter | B. Jung-Hynes | N. Ahmad | Russel J Reiter | Brittney Jung-Hynes | Brittney Jung‐Hynes | Brittney D. Jung-Hynes
[1] R. Klopp,et al. Lymphocyte-induced angiogenesis factor is produced by L3T4+ murine T lymphocytes, and its production declines with age , 1988, Cancer Immunology, Immunotherapy.
[2] J. Barrett,et al. The oncostatic action of melatonin in an ovarian carcinoma cell line , 1999, Journal of pineal research.
[3] F. Alt,et al. Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[4] R. Stevens. Light-at-night, circadian disruption and breast cancer: assessment of existing evidence. , 2009, International journal of epidemiology.
[5] Lu Li,et al. Downregulation of Sirt1 by antisense oligonucleotides induces apoptosis and enhances radiation sensitization in A549 lung cancer cells. , 2007, Lung cancer.
[6] Steven M. Reppert,et al. Posttranslational Mechanisms Regulate the Mammalian Circadian Clock , 2001, Cell.
[7] A. Klar,et al. MAR1-a Regulator of the HMa and HMalpha Loci in SACCHAROMYCES CEREVISIAE. , 1979, Genetics.
[8] H. Wijnen. A Circadian Loop asSIRTs Itself , 2009, Science.
[9] D. Mecke,et al. Diminished Pineal Function Coincides with Disturbed Circadian Endocrine Rhythmicity in Untreated Primary Cancer Patients , 1994, Annals of the New York Academy of Sciences.
[10] J. Takahashi,et al. Circadian Clock Feedback Cycle Through NAMPT-Mediated NAD+ Biosynthesis , 2009, Science.
[11] S. Baylin,et al. Tumor Suppressor HIC1 Directly Regulates SIRT1 to Modulate p53-Dependent DNA-Damage Responses , 2005, Cell.
[12] W. Ershler. Cancer: a disease of the elderly. , 2003, The journal of supportive oncology.
[13] J. Boeke,et al. The biochemistry of sirtuins. , 2006, Annual review of biochemistry.
[14] F. Peyrot,et al. Potential role of tryptophan derivatives in stress responses characterized by the generation of reactive oxygen and nitrogen species , 2008, Journal of pineal research.
[15] H. Korf,et al. Immunocytochemical demonstration of day/night changes of clock gene protein levels in the murine adrenal gland: differences between melatonin‐proficient (C3H) and melatonin‐deficient (C57BL) mice , 2006, Journal of pineal research.
[16] R. Reiter,et al. Melatonin: The chemical expression of darkness , 1991, Molecular and Cellular Endocrinology.
[17] R. Hardeland. Melatonin, hormone of darkness and more – occurrence, control mechanisms, actions and bioactive metabolites , 2008, Cellular and Molecular Life Sciences.
[18] R. Marmorstein. Structure and chemistry of the Sir2 family of NAD+-dependent histone/protein deactylases. , 2004, Biochemical Society transactions.
[19] D. Blask,et al. Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy. , 2002, Current topics in medicinal chemistry.
[20] Oscar M. Aparicio,et al. Modifiers of position effect are shared between telomeric and silent mating-type loci in S. cerevisiae , 1991, Cell.
[21] P. Lansdorp,et al. The Mammalian SIR2α Protein Has a Role in Embryogenesis and Gametogenesis , 2003, Molecular and Cellular Biology.
[22] F. Lévi,et al. Chronotherapy for cancer. , 2003, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[23] David E. Blask,et al. Light During Darkness and Cancer: Relationships in Circadian Photoreception and Tumor Biology , 2006, Cancer Causes & Control.
[24] R. Reiter,et al. Light at night, chronodisruption, melatonin suppression, and cancer risk: a review. , 2007, Critical reviews in oncogenesis.
[25] J. González‐Gallego,et al. Melatonin induces cell cycle arrest and apoptosis in hepatocarcinoma HepG2 cell line , 2008, Journal of pineal research.
[26] R. Reiter,et al. Melatonin: reducing the toxicity and increasing the efficacy of drugs , 2002, The Journal of pharmacy and pharmacology.
[27] H. Manev,et al. The melatonin receptor MT1 is required for the differential regulatory actions of melatonin on neuronal ‘clock’ gene expression in striatal neurons in vitro , 2009, Journal of pineal research.
[28] R. N. Gelder. Non-Visual Photoreception: Sensing Light without Sight , 2008, Current Biology.
[29] L. Tanoue. Cancer Statistics, 2009 , 2010 .
[30] D. Blask,et al. Putting cancer to sleep at night , 2005, Endocrine.
[31] L. Kothari. Influence of chronic melatonin on 9,10-dimethyl-1,2-benzanthracene-induced mammary tumors in female Holtzman rats exposed to continuous light. , 1987, Oncology.
[32] B. Jung-Hynes,et al. Role of Sirtuin Histone Deacetylase SIRT1 in Prostate Cancer , 2009, Journal of Biological Chemistry.
[33] F. Halberg,et al. Circadian gene mPer2 overexpression induces cancer cell apoptosis , 2006, Cancer science.
[34] Nan Li,et al. A universal pattern of mortality decline in the G7 countries , 2000, Nature.
[35] S. Gery,et al. The role of circadian regulation in cancer. , 2007, Cold Spring Harbor symposia on quantitative biology.
[36] P. Sassone-Corsi,et al. Chromatin remodeling, metabolism and circadian clocks: the interplay of CLOCK and SIRT1. , 2009, The international journal of biochemistry & cell biology.
[37] L. N. Valenti,et al. Nuclear Trapping of the Forkhead Transcription Factor FoxO1 via Sirt-dependent Deacetylation Promotes Expression of Glucogenetic Genes* , 2005, Journal of Biological Chemistry.
[38] W. Hrushesky. Circadian timing of cancer chemotherapy. , 1985, Science.
[39] Z. Lou,et al. A c-Myc–SIRT1 feedback loop regulates cell growth and transformation , 2009, The Journal of cell biology.
[40] Florian Kreppel,et al. SIRT1 Regulates Circadian Clock Gene Expression through PER2 Deacetylation , 2008, Cell.
[41] R. E. Esposito,et al. A new role for a yeast transcriptional silencer gene, SIR2, in regulation of recombination in ribosomal DNA , 1989, Cell.
[42] W. Hrushesky,et al. Circadian rhythms and cancer chemotherapy. , 1996, Critical reviews in eukaryotic gene expression.
[43] E. Haus. Chronobiology of the mammalian response to ionizing radiation potential applications in oncology , 2002, Chronobiology international.
[44] Wei Gu,et al. Acetylation inactivates the transcriptional repressor BCL6 , 2002, Nature Genetics.
[45] H. Kolstad. Nightshift work and risk of breast cancer and other cancers--a critical review of the epidemiologic evidence. , 2008, Scandinavian journal of work, environment & health.
[46] M. Pallàs,et al. Evaluation of potential pro‐survival pathways regulated by melatonin in a murine senescence model , 2008, Journal of pineal research.
[47] C. Chen,et al. SIRT1 is critical regulator of FOXO-mediated transcription in response to oxidative stress. , 2005, International journal of molecular medicine.
[48] R. Reiter,et al. Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin , 2009, Critical reviews in biochemistry and molecular biology.
[49] J. Johnson,et al. Age-associated reduction in nocturnal pineal melatonin levels in female rats. , 1981, Endocrinology.
[50] L. Forman,et al. Sirtuin 1 is required for antagonist-induced transcriptional repression of androgen-responsive genes by the androgen receptor. , 2007, Molecular endocrinology.
[51] Yoshiyuki Watanabe,et al. Prospective cohort study of the risk of prostate cancer among rotating-shift workers: findings from the Japan collaborative cohort study. , 2006, American journal of epidemiology.
[52] P. Hornsby. Replicative senescence and cancer. , 2005, Cancer treatment and research.
[53] S. Shimba,et al. Crosstalk between the AHR signaling pathway and circadian rhythm. , 2009, Biochemical pharmacology.
[54] M. Fraga,et al. Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect , 2009, Oncogene.
[55] B. Jung-Hynes,et al. Role of p53 in the anti-proliferative effects of Sirt1 inhibition in prostate cancer cells , 2009, Cell cycle.
[56] S. Nicosia,et al. Suppression of FOXO1 activity by FHL2 through SIRT1‐mediated deacetylation , 2005, The EMBO journal.
[57] M. Bizzarri,et al. Evidence for a biphasic apoptotic pathway induced by melatonin in MCF‐7 breast cancer cells , 2009, Journal of pineal research.
[58] G. Park,et al. SIRT1 promotes DNA repair activity and deacetylation of Ku70 , 2007, Experimental & Molecular Medicine.
[59] R. Weinberg,et al. hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase , 2001, Cell.
[60] C. Meyer. Survival Under Stress , 2002 .
[61] Robert P. Tirrell,et al. Antineoplastic effects of melatonin on a rare malignancy of mesenchymal origin: melatonin receptor‐mediated inhibition of signal transduction, linoleic acid metabolism and growth in tissue‐isolated human leiomyosarcoma xenografts , 2009, Journal of pineal research.
[62] S. Minucci,et al. Human SIR2 deacetylates p53 and antagonizes PML/p53‐induced cellular senescence , 2002, The EMBO journal.
[63] M. McBurney,et al. SirT1-null mice develop tumors at normal rates but are poorly protected by resveratrol , 2009, Oncogene.
[64] N. Ahmad,et al. Melatonin in cancer management: progress and promise. , 2006, Cancer research.
[65] Y. Ouchi,et al. Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras–MAPK signaling in human cancer cells , 2006, Oncogene.
[66] N. Pattabiraman,et al. Hormonal Control of Androgen Receptor Function through SIRT1 , 2006, Molecular and Cellular Biology.
[67] Brian K. Kennedy,et al. Sirtuins in Aging and Age-Related Disease , 2006, Cell.
[68] J. Kurtz. How to predict the risk of local relapse in the preserved breast. , 1996, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[69] C. Deng,et al. Recent progress in the biology and physiology of sirtuins , 2009, Nature.
[70] Steven P. Gygi,et al. Stress-Dependent Regulation of FOXO Transcription Factors by the SIRT1 Deacetylase , 2004, Science.
[71] V. Anisimov,et al. Melatonin and colon carcinogenesis: I. Inhibitory effect of melatonin on development of intestinal tumors induced by 1,2-dimethylhydrazine in rats. , 1997, Carcinogenesis.
[72] A. Reinberg,et al. Chemotherapy of advanced ovarian cancer with 4'-O-tetrahydropyranyl doxorubicin and cisplatin: a randomized phase II trial with an evaluation of circadian timing and dose-intensity. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[73] F. Lévi,et al. Tumor-based rhythms of anticancer efficacy in experimental models , 2002, Chronobiology international.
[74] R. Girgert,et al. Membrane‐bound melatonin receptor MT1 down‐regulates estrogen responsive genes in breast cancer cells , 2009, Journal of pineal research.
[75] Eric Verdin,et al. Mammalian Sir2 Homolog SIRT3 Regulates Global Mitochondrial Lysine Acetylation , 2007, Molecular and Cellular Biology.
[76] G. Eichele,et al. The mPer2 gene encodes a functional component of the mammalian circadian clock , 1999, Nature.
[77] Thomas C Erren,et al. Defining chronodisruption , 2009, Journal of pineal research.
[78] P. Sassone-Corsi,et al. Circadian Control of the NAD+ Salvage Pathway by CLOCK-SIRT1 , 2009, Science.
[79] Delin Chen,et al. Negative Control of p53 by Sir2α Promotes Cell Survival under Stress , 2001, Cell.
[80] L. Fu,et al. The circadian clock: pacemaker and tumour suppressor , 2003, Nature Reviews Cancer.
[81] Giuseppe Tonini,et al. Cancer chronotherapy: Principles, applications, and perspectives , 2003, Cancer.
[82] T. Wang,et al. Chronic inflammation, the tumor microenvironment and carcinogenesis. , 2009, Cell cycle.
[83] W. Gu,et al. Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage , 2006, Nature Cell Biology.
[84] D. Kennaway,et al. Melatonin and activity rhythm responses to light pulses in mice with the Clock mutation. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.
[85] Cantab Ma. John Crighton Bramwell. , 1976 .
[86] T. Holford,et al. Clock-cancer connection in non-Hodgkin's lymphoma: a genetic association study and pathway analysis of the circadian gene cryptochrome 2. , 2009, Cancer research.
[87] R. Reiter,et al. Role of melatonin in the epigenetic regulation of breast cancer , 2009, Breast Cancer Research and Treatment.
[88] Akila N Viswanathan,et al. Circulating melatonin and the risk of breast and endometrial cancer in women. , 2009, Cancer letters.
[89] David Sinclair,et al. Sirtuins in mammals: insights into their biological function. , 2007, The Biochemical journal.
[90] R. Reiter,et al. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. , 1991, Endocrine reviews.
[91] C. Deng,et al. Interplay among BRCA1, SIRT1, and Survivin during BRCA1-associated tumorigenesis. , 2008, Molecular cell.
[92] R. Reiter,et al. One molecule, many derivatives: A never‐ending interaction of melatonin with reactive oxygen and nitrogen species? , 2007, Journal of pineal research.
[93] Y. Akao,et al. A role for SIRT1 in cell growth and chemoresistance in prostate cancer PC3 and DU145 cells. , 2008, Biochemical and biophysical research communications.
[94] Paolo Sassone-Corsi,et al. Circadian Regulator CLOCK Is a Histone Acetyltransferase , 2006, Cell.
[95] R. Stevens. Electric light causes cancer? Surely you're joking, Mr. Stevens. , 2009, Mutation research.
[96] Josep M. Guerrero,et al. Melatonin inhibits telomerase activity in the MCF‐7 tumor cell line both in vivo and in vitro , 2003, Journal of pineal research.
[97] P. Kyyrönen,et al. Night‐time work predisposes to non‐Hodgkin lymphoma , 2008, International journal of cancer.
[98] Manel Esteller,et al. Cross‐Talk between Aging and Cancer , 2007, Annals of the New York Academy of Sciences.
[99] W. Ershler,et al. Cancer and ageing: a nexus at several levels , 2005, Nature Reviews Cancer.
[100] W. Gu,et al. SIRT1 Deacetylation and Repression of p300 Involves Lysine Residues 1020/1024 within the Cell Cycle Regulatory Domain 1* , 2005, Journal of Biological Chemistry.
[101] Ueli Schibler,et al. The circadian PAR-domain basic leucine zipper transcription factors DBP, TEF, and HLF modulate basal and inducible xenobiotic detoxification. , 2006, Cell metabolism.
[102] A. Rebbaa,et al. Control of multidrug resistance gene mdr1 and cancer resistance to chemotherapy by the longevity gene sirt1. , 2005, Cancer research.
[103] Thomas C. Erren,et al. Light, timing of biological rhythms, and chronodisruption in man , 2003, Naturwissenschaften.
[104] R. Reiter,et al. Melatonin induces mitochondrial‐mediated apoptosis in human myeloid HL‐60 cells , 2009, Journal of pineal research.
[105] S. Flüchter,et al. Evidence for Modulation of Melatonin Secretion in Men With Benign and Malignant Tumors of the Prostate: Relationship With the Pituitary Hormones , 1985, Journal of pineal research.
[106] B. Jung-Hynes,et al. SIRT1 controls circadian clock circuitry and promotes cell survival: a connection with age‐related neoplasms , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[107] M. Lippman,et al. ROLE OF PINEAL GLAND IN ÆTIOLOGY AND TREATMENT OF BREAST CANCER , 1978, The Lancet.
[108] D. Cardinali,et al. Melatonin: Nature's most versatile biological signal? , 2006, The FEBS journal.
[109] L. Guarente,et al. Negative control of p53 by Sir2alpha promotes cell survival under stress. , 2001, Cell.
[110] J. Broach,et al. Transcriptional silencing in yeast is associated with reduced nucleosome acetylation. , 1993, Genes & development.
[111] R. Reiter,et al. A generalized theory of carcinogenesis due to chronodisruption. , 2008, Neuro endocrinology letters.
[112] M. A. Rol,et al. Effects of exogenous melatonin and circadian synchronization on tumor progression in melanoma‐bearing C57BL6 mice , 2008, Journal of pineal research.
[113] Pingfang Liu,et al. Genomic Instability and Aging-like Phenotype in the Absence of Mammalian SIRT6 , 2006, Cell.
[114] Paolo Sassone-Corsi,et al. The NAD+-Dependent Deacetylase SIRT1 Modulates CLOCK-Mediated Chromatin Remodeling and Circadian Control , 2008, Cell.
[115] Ming-Feng Hou,et al. Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. , 2005, Carcinogenesis.
[116] C. Infante-Rivard,et al. Circadian time-dependent response of childhood lymphoblastic leukemia to chemotherapy: a long-term follow-up study of survival. , 1993, Chronobiology international.
[117] P. Lansdorp,et al. The mammalian SIR2alpha protein has a role in embryogenesis and gametogenesis. , 2003, Molecular and cellular biology.
[118] E. Bober,et al. Sirt7 Increases Stress Resistance of Cardiomyocytes and Prevents Apoptosis and Inflammatory Cardiomyopathy in Mice , 2008, Circulation research.
[119] B. Ishizuka,et al. Differential growth inhibitory effect of melatonin on two endometrial cancer cell lines , 2000, Journal of pineal research.
[120] Peng Huang,et al. The Circadian Gene Period2 Plays an Important Role in Tumor Suppression and DNA Damage Response In Vivo , 2002, Cell.
[121] I. Herskowitz,et al. Four genes responsible for a position effect on expression from HML and HMR in Saccharomyces cerevisiae. , 1987, Genetics.
[122] K. Yu,et al. Variants in circadian genes and prostate cancer risk: a population-based study in China , 2007, Prostate Cancer and Prostatic Diseases.
[123] T. Ikejima,et al. Roles of SIRT1 and phosphoinositide 3-OH kinase/protein kinase C pathways in evodiamine-induced human melanoma A375-S2 cell death. , 2005, Journal of pharmacological sciences.
[124] J. M. Sherman,et al. The SIR2 gene family, conserved from bacteria to humans, functions in silencing, cell cycle progression, and chromosome stability. , 1995, Genes & development.
[125] U. Albrecht. The mammalian circadian clock: a network of gene expression. , 2004, Frontiers in bioscience : a journal and virtual library.
[126] Richard A. Flavell,et al. All's well that ends dead , 1999 .
[127] K. Stebelová,et al. Effect of rhythmic melatonin administration on clock gene expression in the suprachiasmatic nucleus and the heart of hypertensive TGR(mRen2)27 rats , 2009, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[128] Patricia A. Wood,et al. Daily coordination of cancer growth and circadian clock gene expression , 2005, Breast Cancer Research and Treatment.
[129] J. Qin,et al. Negative regulation of the deacetylase SIRT1 by DBC1 , 2008, Nature.
[130] W. Ying. NAD+ and NADH in cellular functions and cell death. , 2006, Frontiers in bioscience : a journal and virtual library.
[131] C. M. Singer,et al. Human Melatonin Production Decreases With Age , 1986, Journal of pineal research.
[132] S. Joo,et al. Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: therapeutic implications for prostate cancer , 2009, Journal of pineal research.
[133] W. Hahn,et al. The SIRT1 Deacetylase Suppresses Intestinal Tumorigenesis and Colon Cancer Growth , 2008, PloS one.
[134] T. Rikiyama,et al. Clock gene mouse period2 overexpression inhibits growth of human pancreatic cancer cells and has synergistic effect with cisplatin. , 2009, Anticancer research.